You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 9, September 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Articles
 This Article
 •References
 •Full text PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hemilaryngectomy for Glottic Carcinoma After Radiation Therapy Failure

John M. DelGaudio, MD; Daniel J. Fleming, MD; Ramon M. Esclamado, MD; William R. Carroll, MD; Carol R. Bradford, MD

Arch Otolaryngol Head Neck Surg. 1994;120(9):959-963.


Abstract

Objective
To determine the efficacy and safety of vertical hemilaryngectomy (VHL) for the treatment of early glottic carcinoma recurrent after radiation therapy (RT).

Design
Retrospective study.

Setting
Major referral center.

Patients
Forty patients were identified who underwent VHL for T1 or T2 glottic carcinoma between July 1975 and March 1991, and all were included in this study. Twenty-two patients had received full-course RT before VHL, and 18 patients underwent primary VHL.

Main Outcome Measures
The local control rates were determined for T1 and T2 tumors in each group, along with actuarial survival rates and complications.

Results
Local control of tumor for VHL after RT failure was 85% for T1 tumors, 78% for T2 tumors, and 82% overall. Three of four of the local failures in this group occurred in patients who had contraindications to VHL. Total laryngectomy for treatment of local failures in this group increased the local control rate to 93% for T1 tumors, 89% for T2 tumors, and 91% overall. Local control rates for the primary VHL group were 90% for T1 tumors, 75% for T2 tumors, and 83% overall. Total laryngectomy for treatment of local recurrences increased local control to 87% for T2 tumors and 89% overall. Five-year actuarial survival was 85% for each group. Delayed tracheal decannulation occurred more frequently in the patients who had undergone RT.

Conclusions
Our results support the oncologic safety and effectiveness of VHL for the surgical treatment of recurrent early glottic carcinomas after RT, with minimal increased morbidity.

(Arch Otolaryngol Head Neck Surg. 1994;120:959-963)



Author Affiliations

From the Department of Otolaryngology–Head and Neck Surgery, The University of Michigan Hospitals, Ann Arbor (Drs DelGaudio, Esclamado, Carroll, and Bradford). At the time of this writing, Dr Fleming was a medical student with the Department of Otolaryngology–Head and Neck Surgery, University of Michigan Hospitals. He is currently with the Department of Otolaryngology–Head and Neck Surgery, University of Texas Health Science Center, San Antonio.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Endoscopic Carbon Dioxide Laser Surgery for Glottic Cancer Recurrence After Radiotherapy: Oncological Results
Ansarin et al.
Arch Otolaryngol Head Neck Surg 2007;133:1193-1197.
ABSTRACT | FULL TEXT  

Salvage Surgery After Radiotherapy for Laryngeal Cancer: From Endoscopic Resections to Open-Neck Partial and Total Laryngectomies
Piazza et al.
Arch Otolaryngol Head Neck Surg 2007;133:1037-1043.
ABSTRACT | FULL TEXT  

Results of Surgical Salvage After Failure of Definitive Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx
Ganly et al.
Arch Otolaryngol Head Neck Surg 2006;132:59-66.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.